CHARLOTTESVILLE, Va., March 23, 2021 (Newswire.com) - RIVANNA®, developers of world-first, imaging-based medical solutions, announces the market introduction of Accuro Second Generation, combining ...
CHARLOTTESVILLE, Va., September 27, 2021 (Newswire.com) - RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial (RCT ...
• and predicts needle direction and distance from the skin to reach target structures. As reported in the study, a patient requesting epidural analgesia for labor presented with a calculated BMI of 64 ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Rivanna Medical announced today that it has begun selling its Accuro device to anesthesia providers as a result of a successful product launch at the annual ...
A literature search was carried out for this briefing in accordance with NICE's interim process and methods statement. This briefing includes the most relevant or best available published evidence ...
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Rivanna Medical announced today that it has received FDA 510(k) clearance to market Accuro™, a handheld and untethered smart phone-sized device that is designed ...
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results